Eupraxia Pharmaceuticals Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $20.3M
Liabilities Breakdown FY2023
Total Liabilities: $19.4M
Asset Breakdown
Total Assets: $20.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.3M | 95.4% |
| Accounts Receivable | $153.7K | 0.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $409.6K | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $361.1K | 1.8% |
Liabilities Breakdown
Total Liabilities: $19.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 6.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.1M | 93.3% |